In recent years, a variety of naturally occurring antibiotics have been recognized that are analogues or derivatives of small peptides and that function by entering susceptible microorganisms via peptide permeases and attacking intracellular targets; the inhibitory agent may be the intact peptide or a moiety released from it by intracellular hydrolysis (Alper & Ames, 1978; Ringrose 1980 Ringrose , 1983 . Before it was fully recognized that nature has for long appreciated the effectiveness of this approach and has evolved inhibitors with integral carrier components that satisfy the structural requirements of peptide permeases, the potential of this mechanism for the rational design of synthetic antibiotics was inferred from early studies on the structural specificities of microbial peptide permeases (Payne, 1972 (Payne, , 1980 . These studies indicated that, in particular, certain modifications could be made to the C-termini and to the side chains of peptides that still allowed them to be transported; if the attached moieties are themselves impermeant, the resultant, peptide derivatives have become referred to as 'smugglins ' (Matthews & Payne, 1975) . Several examples of such derivatives have been described (e.g., Ames et al., 1973; Fickel & Gilvarg, 1973; Diddens et al., 1976 ; for review, see Ringrose, 1980) . The most extensively studied are analogues in which the C-terminal carboxy group is replaced by phosphonate, e.g. Ala-Ala-phosphonate (alafosfalin), or other acidic groups, which may have high antibiotic activity against Escherichia coli and other clinically important bacterial species (Allen et a / . , 1978; Atherton et a/., Ringrose, 1980 Ringrose, , 1983 .
To date, however, little attention has been paid to the antibiotic possibilities of analogues in which parts of the backbone other than the C-terminus have been modified. Results of other studies (Briggs & Morley, 1979; Morley, 1980) indicate that such modifications are often associated with increased resistance to mammalian peptidases, a property that would be a sought-after design feature in an antibacterial peptide for use in man. Accordingly, we have prepared a range of backbonemodified analogues of Ala-Ala and of Ala-Ala-Ala, and investigated their activity in vitro against E. coli, Staphylococcus aureus and Salmonella dublin together with a study of their uptake into E. coli.
Peptide analogues with modified backbone structures
The relationship of the structure of these analogues to the parent peptide, Ala-Ala, is shown in Fig. 1 . In the backbone-modified analogues, the usual peptide linkage (-CO-NH-) was reversed (-NH-CO-) (retro-analogues), replaced by -CO-NH-NH (hydrazino-analogues) or by -CO-NHO-(aminoxy-analogues), or an a-carbon atom was replaced by a nitrogen atom (a-aza-analogues). For comparison, two other types of analogue were prepared in which the C-terminal (Morley, I98 I) for the systematic description of peptides containing modified peptide linkages leads to the following abbreviations for these analogues : Ala-ly ( NH-C0)-Ala (retro), Ala-ly(C0-N H-N H)-Ala (hydrazino) and Ala-ly(C0-NH-0)-Ala (aminoxy). However, for convenience, in the present paper the following simpler forms are used: Ala-NH-Ala, for hydrazino analogues; for the aminoxy derivatives, OAla and D-OAla to denote respectively L-or D-2-aminoxypropionic acid; and AlaT to describe ~-2 -( I-aminoethyI)tetrazole, the tetrazole analogue of Ala.
Antibacterial activity and transport of peptide analogues
The concentration of each analogue that inhibited growth by 50% (IDjo) was determined from incubations in glucose/NH,+ minimal liquid medium at 37OC. The results of such tests against a wild-type strain of E. coli K12 and an oligopeptide-permease-deficient mutant (opp) derived from it I selected as being spontaneously resistant to the toxic peptide Om-Orn-Orn (Payne, 1980) ) showed (Table 1) no inhibitory effect at any tested concentration with the following substances: the parent di-and tri-peptides; the aza-analogues carrying either a free or an amidated C-terminal carboxy group; the di-and tri-peptide hydroxamic-and tetrazole-analogues; and the tripeptide retro-analogue. Accordingly, the antibacterial activity of these analogues against other species was not examined. Subsequently, measurements were made of the uptake (Payne & Bell, 1979; Payne & Nisbet, 1981) of these analogues by E. coli to see if this feature could be correlated with their lack of antibacterial activity (Table I ). For these tests a different strain of E. coli was used, but related studies indicated that it showed the same spectrum of sensitivities to these and other analogues (see below) as did the K 12 strain (Morley et al., 1983) . These studies showed that. as expected (Payne & Bell, 1979) , the parent peptides were taken up rapidly. cleaved intracellularly and their constituent alanine residues underwent rapid exodus: clearly, neither the peptides nor their amino acid residues are toxic. For the hydroxamic-. retro-and tetrazole-analogues, significant. although relatively lower, rates of uptake occurred, and some hydrolysis was noted: it must be concluded, therefore, that none of the parent peptides or any hydrolytic fragments possess significant toxicity. However, for the aza-derivatives uptake was not detectable ( Table I) . which can explain their lack of antibacterial activity. Clearly, this observation precludes any conclusion regarding the inherent toxicity of these analogues towards intracellular targets.
In contrast with the analogues studied above, the aminoxyand hydrazino-derivatives were highly active against wild-type E. coli ( Table 2 ) ; comparable results were obtained with different strains assayed in liquid media and on agar plates. In both instances it is noticeable that there is a significant enhancement in toxicity when the amino acid analogue is present in peptide linkage rather than in free form. At similar concentrations. the dipeptide analogues were equally active against the opp strains. whereas these mutants were generally markedly resistant to the tripeptide analogues; these differences reflect the various substrate specificities of the dipeptide-, tripeptide-and oligopeptide-permeases present in E. coli (Payne, 1983) . Both types of analogue were active against Salm. dublin, and the tripeptide analogues showed limited activity against Staph. aureus ( Table 2 ).
The two hydrazino-. but not the two aminoxy-. analogues were found to be toxic to mice at low concentrations (results not shown). Interest focused, therefore, on the aminoxy series and an extended range of aminoxy-analogues was prepared and their antibacterial activities measured (Morley et al.. 1983) . Briefly, these studies showed that the activity of analogues wherein the aminoxy residue was at the C-terminus and of the L-configuration varied markedly dependent upon the nature of the other residues in the molecule (see below). Dipeptide analogues were generally equiactive against wild-type and opp strains, whereas tripeptide analogues were generally less active against the latter mutants.
To see whether these different toxicity patterns were explicable in terms of the transport characteristics of the substrates, uptake was measured in E. coli (Table 2 ; see also Morley et d.. 1983). Uptake of both the hydrazino-derivatives and the extended range of aminoxy-analogues was generally fast and comparable with that of the unmodified peptides (Table 2) .
Studies with a range of peptide permease mutants indicated that all three permeases (Payne, 1980 (Payne, , 1983 could handle these backbone-modified substrates. Specificity was endowed by the N-terminal residues, with lysine, valine and proline conferring specificity for uptake by dpp, ipp and opp respectively; Nterminal alanine analogues were recognized by all three systems.
Five analogues were prepared wherein the C-terminal aminoxy residue was of the D-COnfigUratiOn. All had high activity against wild-type and opp strains of E . coli, and considerable activity was also shown against Salm. dublin and Staph. aureus; all of those tested showed rapid uptake by E. coli (Morley et al., 1983) . In addition, these analogues were cleaved ~~ ~ Table I . Antibacierial actiilities and uptake rates of peptide analogues
Units for uptake rate are arbitrary on a scale from 0 to 5 . An uptake rate of 5 on this scale is equivalent to approx. Table 2 . A ntibacierial activities and uptake rates of aminoxy and hvdrazino peptide analogues
For explanation and definition of units for uptake rate, see the legend to Table I . intracellularly and the released protein amino acid residues underwent exodus concomitant with continued peptide uptake; in this respect therefore they are similar to normal peptides (Payne & Bell, 1979; Payne, 1980) .
Permease and peptidase specificities
From amongst the fairly limited range of analogues described here, in which the peptide backbone or C-terminus has been modified, it is of some significance that two new classes of powerful antibacterial agents have been discovered, viz., aminoxy-and hydrazino-analogues of simple di-and tripeptides. The enhanced activity displayed when these 'unnatural' moieties are incorporated into a peptide rather than in the free form implies a carrier role for the peptide component and an intracellular target for the toxic component. This conclusion was endorsed by the finding that mutations in peptide permeases can confer resistance to the peptide analogues (Morley et al., 1983) . From these inhibitor studies, and from the results of direct transport assays, one can infer new information on the structural specificities of these permeases.
The recognition by all three permeases of these backbone-modified structures unambiguously demonstrates that there is no absolute requirement for the normal peptide linkage. That the dipeptide permease, dpp, can seemingly also recognize substrates with an extended structure complements recent observations on the specificities of this system (Payne, 1983) . Of particular interest is the finding that dipeptide analogues containing D-aminoxy-modified residues are absorbed well (Morley et al., 1983) ; this is in contrast with the usual case that dipeptides containing D-amino acid residues are not transported (Payne, 1980) . This finding calls for a reconsideration of the stereochemical specificity for dipeptide uptake.
Peptidase activity against the aminoxy-derivatives also revealed novel features. Whole cells of E. coli rapidly cleaved the aminoxy-analogues, indicating here also a lack of specificity for the 'normal' peptide linkage. Indeed, rates of cleavage measured in crude cell extracts were comparable for Ala-OAla and a variety of typical dipeptides (Morley et al., 1983) . Cleavage of analogues with D-residues was also considerable, in contrast with findings with normal peptides containing D-amino acid residues (Hermsdorf & Simmonds, 1980; Payne & Nisbet, 1980) . Finally, the contrast should be noted between the ease with which the aminoxy-derivatives are cleaved by E. coli peptidases and their considerable resistance to mammalian proteolysis (Briggs & Morley, 1979) .
It seems probable from the foregoing that the aminoxyanalogues function in a similar manner to alafosfalin (Atherton et al., 1979) . i.e. by being transported via peptide permeases, and hydrolysed by intracellular peptidases thereby releasing a toxic residue (2-aminoxypropionic acid) that cannot readily leave the cell. The possibility that the intact analogue might also have inhibitory activity cannot yet be ruled out. The exact mode of action of these inhibitors has yet to be clarified (Morley et al., 1983) .
it has become clear in recent years that the distribution of peptide-transport systems is widespread amongst microorganisms (Payne, 1980; Payne & Gilvarg, 1978; Becker & Naider, 1980) and in mammalian tissues (Matthews, 1975;  .Matthews & Payne, 1980) . These peptide-transport systems usually occur alongside. and function in a complementary manner to, systems for transporting amino acids. However, compared with amino-acid uptake, peptide transport has many advantages, e.g., in terms of energy efficiency, a more balanced presentation of amino acid residues, etc. It seemed likely to us. therefore, that peptide-transport systems would also occur in plants. The question was, where to look for their occurrence? Because plants are generally autotrophic, and the use of external sources of organic nitrogen is usually unimportant, we chose to look first within the plant. Likely places seemed to be in senescing tissues and germinating seeds, where protein breakdown and mobilization is pronounced. We chose the latter as the easier system to study, and barley in particular because of the extensive relevant information already in the literature concerning proteolytic events accompanying germination. Indeed, although at this time (1977) . it was generally assumed that the transfer of nitrogenous compounds from the endosperm to
